A pilot study to assess the feasibility of measuring the prevalence of slow colon transit or evacuation disorder in palliative care by Clark, Katherine & Currow, David Christopher
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Archived at the Flinders Academic Commons: 
http://dspace.flinders.edu.au/dspace/ 
This is a copy of an article published in the Journal of 
Palliative Medicine, © 2013 copyright Mary Ann Liebert, 
Inc.; the Journal of Palliative Medicine is available online at: 
http://online.liebertpub.com 
Please cite this as: Clark, K. and Currow, D.C., 2013. A pilot 
study to assess the feasibility of measuring the prevalence 
of slow colon transit or evacuation disorder in palliative 
care. Journal of Palliative Medicine, 16(5), 542-545. 
doi:10.1089/jpm.2012.0379  
© 2013 Mary Ann Liebert, Inc. Published version 
reproduced here in accordance with the policy of the 
publisher. 
A Pilot Study To Assess the Feasibility of Measuring
the Prevalence of Slow Colon Transit or Evacuation
Disorder in Palliative Care
Katherine Clark, MB BS MMED FRACP1,2 and David C. Currow, MPH, FRACP3
Abstract
Context: Constipation is prevalent in palliative care. Whilst numerous factors contribute to this problem, opioid
analgesia remains the most quoted aetiology. However, in gastroenterology, constipation is classified as a
problem of prolonged transit times of colonic contents, impaired function of the structures of defecation or both.
Little work in palliative care has used these assessments.
Aims: The report aims to describe the feasibility of assessing the colon transit times and pelvic floor structures of
constipated palliative care patients and to report the results of a pilot study of 10 people who underwent these
investigations.
Methods: Colon transit times were measured with a combination of orally administered radio-opaque markers
and a single plain radiograph of the abdomen at day 5. Anal manometry plus rectal balloon expulsion was used
to assess the pelvic floor. The results of the investigations were used to allocate people to one of four constipation
subcategories: 1). slow colonic transit; 2) evacuation disorders; 3) mixed disorder or 4) normal transit.
Results: Two people had slow transit only, 2 people had evacuation disorders only and 5 had both. Only person
had neither problem. The investigations were well tolerated and took a small amount of people’s time.
Conclusion: These pilot data strongly support the feasibility of undertaking comprehensive assessments of the
colon and pelvic floor in palliative care patients with the results, although preliminary, highlighting the complexity
of the problem of constipation. The results of this work underpin the need to progress to a much larger study.
Introduction
Constipation is a significant problem in palliative careand hospice. Observational studies report up to 60% of
people at the time of admission to a palliative care unit are
prescribed laxatives, with more than half of these receiving
two or more laxatives simultaneously.1 Despite the use of
laxatives, many people continue to describe constipation
symptoms and dissatisfaction with their symptom manage-
ment.2 The magnitude of the problem in palliative care is
highlighted when the number of people prescribed laxatives
in hospice/palliative care is compared with the overall pop-
ulation. Even in the 30% of people who experience some de-
gree of functional constipation across their lifespan, only one
in six of this group require laxatives.3
Gastroenterologists describe constipation as a physical
problem of either the colon or supporting pelvic structures.4
Practise guidelines in gastroenterology recommend that these
structures be assessed to best define the physical abnormality
underlying difficult constipation symptoms. This requires at a
minimum, measurement of colon transit time, anorectal ma-
nometry and rectal balloon expulsion.5 This approach has
allowed identification of constipation subcategories including
slow transit constipation, disordered defecation and normal
transit constipation.6 The most important reason to identify
the underlying problem is that this then allows the most ap-
propriate interventions for the particular problem to be initi-
ated which for many people, may influence their response to
treatment.7
Adopting this same premise in hospice/palliative care
makes sense given that the same structures of bowel function
and defecation must be involved. However, it is likely that
these structures become compromised by progressive disease
processes and treatments. For example, there are numerous
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factors likely to reduce colon transit times in palliative care.
Such factors include medications such as opioids or medica-
tions with anticholinergic effects, metabolic factors, reduced
activity and reduced oral intake. Furthermore, there are other
factors which potentially could affect the pelvic floor includ-
ing myopathic and neuropathic processes. To date, very little
attention has ever been paid to the possibility that changes in
the pelvic floor could influence the constipation symptoms
experienced by constipated people with palliative care needs.
The only way to objectively explore this further is for pallia-
tive care/hospice clinicians to adopt the same approaches
recommended by gastroenterologists to assess the colon and
structures of defecation.
The aim of this pilot study is to describe the feasibility of
adopting simple but validated approaches tomeasuring colon
transit times, anal manometry and rectal balloon expulsion in
a palliative care population and to report the results of these
assessments in 10 participants, drawn from a specialist palli-
ative care service, well enough and able to participate. The
results of this pilot will be used to inform amuch larger study.
Methods
Study population
This study was conducted in adults with constipation
currently under the care of a specialist palliative care service.
To be included, people had to be taking regular laxatives
prescribed according to Australian clinical guidelines as
summarised in table 1;8 an intact colon, rectum and anus;
prognosis of at least 2 months in the opinion of the treating
physician; and willingness to participate in the assessment
processes to categorise constipation.
People were excluded if they had a poor performance sta-
tus (Australian-modified Karnofsky performance status £ 40);
had participated in a clinical study of a new laxative in the
week prior to study entry; short-term constipation due to
problems such hypercalcaemia or vinca alkylating agents;
local conditions of the peri-anal area and rectum that would
contribute to pain on defecation or conditions including faecal
impaction, anal fissure, haemorrhoids, anal prolapse or rec-
tocele > 2 cm in size; thrombocytopenia of < 50,000 platelets
per microliter or neutropenia of < 2· 109/L or any other
condition that would interfere with study procedures or as-
sessments in the opinion of the investigators.
Study setting
This study was conducted at a regional tertiary palliative
care unit with a referral base predominately of people with
cancer.
Study investigations
After providing written informed consent, a series of in-
vestigationswas organised. Colon transit timesweremeasured
with a single plain abdominal radiograph to track the progress
of orally administered radio-opaque markers. The protocol
adopted for this work involves the administration of a single
capsule containing twenty four 4.5mmmarkers followed by a
plain radiograph on the 6th day after ingestion. More than 5
markers visible on a plain abdominal radiograph has been
identified as diagnostic of slow colon transit times.9
Structures of defecation were assessed with anal manom-
etry and rectal balloon expulsion. Anal manometry was per-
formed at the bedside using a perinometer. This is a simple
device that records average anal pressures.10 The average
resting pressure predominantly reflects the internal anal
sphincter. Squeeze pressure mostly reflects the external anal
sphincter and puborectalis sling. Low or poorly sustained
squeeze pressures implies weakness of the pelvic floor. As it is
difficult with these simple devices to differentiate between
compromised muscle integrity or impaired innervation or
both, cough pressure was also collected. Measuring average
anal pressure during coughing was undertaken to evaluate
whether the rectoanal contractile reflex was intact.11
Rectal balloon expulsion was included in the investiga-
tions. This is another test that provides a simple physiologic
assessment of simulated defecation. A catheter is inserted into
the rectum and the balloon of the catheter is inflated with
50mls of fluid. Failure to expel the balloon in less than 60
seconds suggests a defecation disorder. Previous work sug-
gests that the balloon expulsion test has a sensitivity of 88%
and positive predictive value of 64% for diagnosing pelvic
floor dysfunction. Furthermore, the specificity is 89%, with a
negative predictive value of 97% for excluding pelvic floor
dysfunction. This means that although the failure to expel a
balloon strongly suggests disturbed defeacation, a normal test
does not exclude this possibility. Balloon expulsion should be
interpreted alongwith other anorectal physiologic tests with a
diagnosis of defecation disorder requiring at least 2 of the 4
parameters measured being abnormal.5,12
These results were then used to identify if people had ob-
jective evidence of constipation diagnostic subcategories
namely: 1). Slow colonic transit (slow transit); 2). Pelvic floor
dysfunction (evacuation disorder); 3). Mixed disorder; or 4).
Normal transit. These approaches were adopted specifically
because they are: validated; haveminimum patient burdens or
risk even in hospice/palliative care patients; and the potential
to help subcategorise constiaptation thereby potentially al-
lowing better targeting of the most appropriate interventions.
Results
Of the 10 people who participated, all had a diagnosis of
cancer underlying their referral to palliative care. The median
age was 66 years (range 49–82) with just over half the group
being men (n = 6). All were taking regular laxatives and one
half described long term bowel dysfunction. (Table 2) All but
Table 1. Management of Constipation According
To Australian Therapeutic Guidelines8
Self-reports of passing soft stool:
docusate + sennoside B 100+ 16mg (= 2 tablets) orally,
once or twice daily.
If second agent needed
bisacodyl 10mg (= 2 tablets) orally, at night, increasing
to a maximum of 10mg twice daily.
+/ - bisacodyl 10mg suppository rectally.
Self-reports of passing hard stool:
docusate + sennoside B 100+ 16mg (= 2 tablets) orally,
once or twice daily
OR
macrogol 3350 1 to 3 sachets in 500ml of water orally,
taken over 2 hours daily
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one was taking opioids with the oral morphine equivalent
doses ranging from 24mg to 440mg.
Five people had both slow colonic transit and a defecation
disorder. (Table 2) A further two people had defeacation
disorder only suggesting that 7/10 had some degree of pelvic
floor dysfunction contributing to their constipation symp-
toms. Likewise 2 people had slow transit alone suggesting
that 7/10 had an element of slow transit contributing to their
constipation symptoms. None of the participants found the
investigations intolerable. Rather one person noted that the
investigations were minimal compared to the distress and
discomfort his disturbed bowel problems had caused him
over a long period of time.
Discussion
This pilot work strongly supports the need to more closely
examine the problem of constipation in palliative care as it is
suggested by this pilot that the problems experienced by
people are the result of a variety of physical changes most
likely occurring as the result of multiple insults. This work
offers a real possibility that in the future, it might be possible
to align management of the problem to people’s underlying
physical disorders, acknowledging that the physical changes
aremost likely to be the result of numerous risk factors carried
by palliative care patients.
Furthermore, the fact that half of the group had both slow
transit and disordered defecation strongly supports the need
for palliative care to consider just how complex constipation
might be and attribute constipation tomore than opioids. This
observation is supported by two points. Firstly, 70% of the
group displayed some degree of defecation difficulties,
problems that have received little attention in palliative care.
This is despite the fact that muscle weakness is acknowledged
as an underlying reason for other problems in palliative care
such as breathlessness. The hallmark of cachexia is muscle
wasting and the muscles of the pelvic floor are unlikely to be
spared. Secondly, slow transit alone was seen in two partici-
pants who were taking relatively low doses of opioids whilst
the two participants with defecation disorders were taking
Table 2. Results of 10 Participants
Patient
No of Markers visible
on abdominal
radiograph
at six days
(Normal transit
< 5/24 markers at 6 days)
Perinometer
readings
(mmH2O)
Balloon
expulsion Interpretation
Self-reported
as having a past
history of
bowel problems
Oral morphine
equivalent
(mg) (11)
1 0 Resting: Low
Squeeze: Low
Cough: Low
Unable Evacuation Disorder No 50mg
2 18 Resting: Low
Squeeze: Low
Cough: Normal
Unable Mixed Yes 300mg
3 17 Resting: Low
Squeeze: Normal
Cough: Normal
Unable Mixed No 440mg
4 11 Resting: Normal
Squeeze: High
Cough: Normal
Unable Mixed Yes 30mg
5 7 Resting: Low
Squeeze: Low
Cough: Low
Unable Mixed N/A 75mg
6 12 Resting: Normal
Squeeze: Normal
Cough: Normal
Unable Slow transit Yes 24mg
7 24 Resting: Normal
Squeeze: Normal
Cough: Normal
Unable Slow transit Yes 50mg
8 21 Resting: Low
Squeeze: Normal
Cough: Normal
Unable Mixed N/A 0
9 3 Resting: Low
Squeeze: Low
Cough: Low
Unable Evacuation disorder N/A 75mg
10 0 Resting: Normal
Squeeze: Normal
Cough: Normal
Unable Normal transit Yes 200mg
N/A – not available
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higher doses of opioids. This is contrary to what would be
expected. Both these observations strongly support the need
to continue this work.
At least half of this group described long term problems
with constipation. It is not clear if this group self-selected to be
involved in this work or if the presence of premorbid prob-
lems influences the severity of experiences people have in
progressive illness. This is another area that requires further
investigation.
The choice of investigations for this pilot work was based
on both previous data which describes the use of these in-
vestigations whilst at the same considering the tolerability of
such investigations in an inherently frail patient population. It
is worth noting that there are a variety of different protocols
for measuring colon transit times with oral capsules and plain
radiographs, most of which require multiple capsule doses
and repeat radiographs. However, all of these approaches are
hindered by a lack of standardisation of the results. Regard-
less, the method adopted to progress this work further is
accepted in clinical practise. This discussion must also be ex-
tended to the balloon expulsion test adopted for this work. So
far, whilst recommended in the assessment of chronic con-
stipation, the balloon expulsion test has not yet been stan-
dardised. Despite this, the balloon expulsion test is considered
best practise when considered along with other tests of the
pelvic floor as has been adopted for this work.
The investigations proved to be acceptable to the par-
ticipants and feasible for a clinical service to perform in a
sub-group of people well enough to tolerate them. For such
people, the burden of ineffectively treated constipation may be
far greater than the inconvenience of three brief and acceptable
tests that help clinicians to target effective therapies.
In conclusion, this pilot strongly supports the need for and
the feasibility of progressing to amuch larger piece of research
that will allow a greater exploration of a number of important
issues that include: 1). Correlating the objectively documented
physical changes with people’s subjective experiences; 2) En-
abling regression assessments of risk factors for constipation
with objectively defined physical sub-groups to define which
risk factors are most clinically relevant; 3). Defining the ac-
ceptability of the approach in a much larger cohort of palliative
care patients; 4). To begin an exploration of whether the man-
agement of constipation is improved by identifying the un-
derlying physical subgroup this person falls into.
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